新产业、新市场与新技术动能澎湃 海尔生物2025年营收23.29亿元

Core Viewpoint - Haier Biomedical demonstrates strong growth resilience with a revenue of 2.329 billion yuan in 2025, reflecting a year-on-year increase of 1.96%, and a notable 13.1% growth in the fourth quarter [1] Group 1: Overseas Development - Haier Biomedical's overseas revenue reached 840 million yuan in 2025, marking a 17.9% increase and accounting for 36% of total revenue, a 5 percentage point increase from 2024 [2] - The company has achieved a compound annual growth rate of over 20% in overseas revenue from 2016 to 2024, with Europe, Asia-Pacific, Americas, and Africa showing growth rates of 16.0%, 26.0%, 12.2%, and 17.8% respectively [2] - Haier Biomedical's Eco-Drive technology enhances efficiency by 30%, achieving the highest energy efficiency in the industry [2] Group 2: Innovation and New Industries - New industries contributed 48.5% of total revenue in 2025, with a year-on-year growth of 8.8%, particularly in smart medication and blood technology [4] - The smart medication sector saw an 18.8% revenue increase, positioning the company among the top three in market share for automated medication [4] - Blood technology revenue grew by 14.8%, with a market share exceeding 50% in plasma collection solutions [4] Group 3: AI and Technological Advancements - AI-related revenue constituted 15% of total revenue in 2025, an increase of 2.5 percentage points from 2024, with a significant reduction in product development cycles by 6% [7] - The company launched 11 new AI-driven products, including fully automated cell culture workstations and automated tumor liquid preparation robots, enhancing its technological capabilities [6] - Collaboration with Guangzhou National Laboratory led to the creation of the world's first fully automated PBMC cell extraction workstation, addressing sample management challenges [6] Group 4: Future Outlook - With the release of new capacities and accelerated innovation, Haier Biomedical is expected to reach a profit turning point in 2026, providing high-quality products and solutions to global users [8]

HAIER BIOMEDICAL-新产业、新市场与新技术动能澎湃 海尔生物2025年营收23.29亿元 - Reportify